Innovative Veterinary Solutions for Antimicrobial Resistance (InnoVet-AMR) is a four-year, CAD26.3 million partnership between IDRC and the UK Department of Health and Social Care (DHSC). The initiative is aimed at reducing the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security.
Through InnoVet-AMR, IDRC and DHSC aim to achieve two main objectives:
- Support research that will identify and develop prophylactic and therapeutic innovative veterinary solutions, including vaccines, to improve health, while reducing the use of antimicrobials in ruminants and aquaculture operations in low- and middle-income countries (LMICs).
- Build effective gender-balanced partnerships to better contribute to the discovery and development of innovative veterinary solutions to reduce the use of antimicrobials in ruminants and aquaculture operations in LMICs.
Eligibility
This initiative will invite research proposals focused on veterinary solutions, where new product-oriented solutions would significantly reduce the therapeutic and/or non-therapeutic use of antimicrobials in low- and middle-income countries in ruminants and/or aquaculture production. These solutions should target the prevention and control of bacterial infectious diseases of importance in low- and middle-income countries and the reduction of the use of antimicrobials while considering gender equity and inclusion and demonstrating commitment to climate change mitigation.
Deadline: October 30, 2023 – 15:00
| Apply now |